and disorder‐generalized mutations. Similarly, our ability to measure the brain's activity during resting state and during various cognitive tasks with exquisite temporal accuracy, allows us to develop and implement EEG protocols that uniquely address questions regarding the course of AUD. While COGA has maintained its focus on EEG, a subset of COGA participants have been imaged using brain Magnetic Resonance Imaging (MRI) allowing for comparisons between these data. 82 Moreover, genetic differences in COGA participants are now being translated into changes in neuronal function using advanced molecular and cellular tools, potentially leading to novel therapeutic strategies for treating AUD.
